News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Amar Kishan: Proud to Share Outcomes for phase II SCIMITAR Trial Published in JAMA Oncology
Amar U Kishan/X
May 16, 2025, 16:21

Amar Kishan: Proud to Share Outcomes for phase II SCIMITAR Trial Published in JAMA Oncology

Amar Kishan, Radiation Oncologist, Professor, and Executive Vice Chair of Radiation Oncology at UCLA, shared a post by JAMA Oncology on X about recent paper he and his colleagues authored, adding:

“Proud to share 2-year patient-reported outcomes for our phase II SCIMITAR trial (NCT03541850) of SBRT to the prostate fossa (with or without nodes), out today in JAMA Oncology.
We were fortunate to have a strong collaborative team UCLA Jonsson Comprehensive Cancer Center including UCLA Urology, as well as a comparator cohort of patients receiving conventionally fractionated IMRT at UChicago Medicine, Stan Liauw and Connor Lynch.
Special kudos to soon-to-be U Penn attending, John Nikitas, who has now pulled off first author papers in JAMA Onc, Lancet Onc, European Urology, Red Journal, and Green Journal in residency!
And thanks to many collaborators including Leslie Ballas, and, most importantly, the patients who enrolled in this trial. Oncologic outcomes (primary endpoint) to be reported at ASTRO 2025.
Editorial by Sean McBride and Howard Scher.”

Quoting JAMA Oncology‘s post:

“Postoperative stereotactic body radiotherapy for prostate cancer was well-tolerated with similar urinary and bowel patient-reported outcomes over two years vs conventional radiotherapy.”

Title: Patient-Reported Outcomes With Stereotactic Intensity Modulated Radiotherapy After Radical Prostatectomy

Journal: JAMA Oncology

Authors: John Nikitas, Leslie K. Ballas, Tahmineh Romero, Connor Lynch, Ting Martin Ma, Luca F. Valle, Ankush Sachdeva, Natalie Chong, Vince Basehart, Antonio Franco, Robert Reiter, Christopher Saigal, Karim Chamie, Mark S. Litwin, Nicholas M. Donin, Matthew Rettig, Nicholas G. Nickols, Minsong Cao, Stanley L. Liauw, Michael L. Steinberg, Amar U. Kishan

Amar Kishan Amar U. Kishan Ankush Sachdeva Antonio Franco cancer Christopher Saigal Connor Lynch John Nikitas Karim Chamie Leslie K. Ballas Luca F. Valle Mark S. Litwin Matthew Rettig Michael L. Steinberg Minsong Cao Natalie Chong Nicholas G. Nickols Nicholas M. Donin OncoDaily Oncology Robert Reiter Stanley L. Liauw Tahmineh Romero Ting Martin Ma Vince Basehart
Special Coverage
Insight
May 16, 2025, 16:21
Amar Kishan: Proud to Share Outcomes for phase II SCIMITAR Trial Published in JAMA Oncology
Science
May 16, 2025, 16:18
Myeloma Paper of the Day, May 16th, suggested by Robert Orlowski
Insight
May 16, 2025, 16:03
START Doses 1st US Patient in Moderna's Pan-Tumor Antigen Therapy Study in Solid Tumors
Blog
May 16, 2025, 15:51
Myeloma Society Call for Abstracts for the 22nd International Myeloma Society Annual Meeting
Blog
May 16, 2025, 15:30
Maria Kavallaris Pays Tribute to Vale Associate Professor Josh McCarroll
Blog
May 16, 2025, 15:04
Elvina Almuradova: Sherene Loi on the Role of Pregnancy and Breastfeeding in Enhancing Early Cancer Detection
Blog
May 16, 2025, 14:53
Tit Albreht Honored with Prestigious Inaugural Award for Improving Cancer Outcomes
Blog
May 16, 2025, 13:31
Anju Aledia: Exploring Science up Close with a Magnifying Glass
Blog
May 16, 2025, 13:24
Amil Družić: The European School of Oncology's Improving Cancer Outcomes and Leadership Course in Zagreb
Oncolibrary
May 16, 2025, 13:21
FDA Approves Retifanlimab-dlwr with Chemotherapy and as Monotherapy for Advanced Squamous Cell Carcinoma of the Anal Canal
Blog
May 16, 2025, 13:01
How Countries are Engaging Stakeholders in the Development and Implementation of NCCPs - Union for International Cancer Control
Oncolibrary
May 16, 2025, 12:59
Eating Well with Mesothelioma: What You Need to Know